tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Technical Analysis

Compare
445 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Spyre Therapeutics’s (SYRE) Moving Averages Convergence Divergence (MACD) indicator is -0.82, suggesting Spyre Therapeutics is a Sell.
Spyre Therapeutics’s (SYRE) 20-Day exponential moving average is 18.65, while Spyre Therapeutics’s (SYRE) share price is $16.14, making it a Sell.
Spyre Therapeutics’s (SYRE) 50-Day exponential moving average is 20.43, while Spyre Therapeutics’s (SYRE) share price is $16.14, making it a Sell.

Spyre Therapeutics (SYRE) Pivot Points

Apr 01, 2025, 09:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.75
16.23
16.96
17.44
18.17
18.65
19.38
Fibonacci
16.23
16.69
16.98
17.44
17.90
18.19
18.65
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Spyre Therapeutics (SYRE) Moving Averages

Apr 01, 2025, 09:29 PM
Period
Simple
Exponential
MA5
17.97Sell
17.88Buy
MA10
18.10Sell
18.09Sell
MA20
18.44Sell
18.65Sell
MA50
20.50Sell
20.43Sell
MA100
23.94Sell
22.90Sell
MA200
26.24Sell
26.15Sell
Spyre Therapeutics’s (SYRE) 10-Day exponential moving average is 18.09, while Spyre Therapeutics’s (SYRE) share price is $16.14, making it a Sell.
Spyre Therapeutics’s (SYRE) 100-Day exponential moving average is 22.90, while Spyre Therapeutics’s (SYRE) share price is $16.14, making it a Sell.
Spyre Therapeutics’s (SYRE) stock price is $16.14 and Spyre Therapeutics’s (SYRE) 50-day simple moving average is 20.50, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $16.14 and Spyre Therapeutics’s (SYRE) 100-day simple moving average is 23.94, creating a Sell signal.
Spyre Therapeutics’s (SYRE) stock price is $16.14 and Spyre Therapeutics’s (SYRE) 200-day simple moving average is 26.24, creating a Sell signal.

Spyre Therapeutics (SYRE) Technical Indicators

Apr 01, 2025, 09:29 PM
Name
Value
Implied Action
RSI (14)
43.06
Neutral
STOCH (9,6)
27.57
Neutral
STOCHRSI (14)
25.80
Neutral
MACD (12,26)
-0.82
Sell
ADX (14)
31.96
Neutral
Williams %R
-57.14
Buy
CCI (14)
-88.90
Neutral
ATR (14)
1.40
-
Ultimate Oscillator
44.23
Neutral
ROC
-3.81
Sell
Spyre Therapeutics’s (SYRE) Relative Strength Index (RSI) is 43.06, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Trend Strength Indicator (ADX) is 31.96, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Commodity Channel Index (CCI) is -88.90, creating a Neutral signal.
Spyre Therapeutics’s (SYRE) Price Rate of Change (ROC) is -3.81, creating a Sell signal.

FAQ

Is SYRE a Buy, Hold, or Sell?
Based on SYRE’s technical indicators, SYRE is a Strong Sell.
    What is SYRE’s RSI (14)?
    SYRE’s RSI (14) is 43.06, which suggests SYRE is a Neutral.
      What is SYRE’s MACD?
      SYRE’s MACD is -0.82, which suggests SYRE is a Sell.
        What is SYRE’s 5-day moving average?
        SYRE’s 5-day moving average is 17.97, which suggests SYRE is a Sell.
          What is SYRE’s 20-day moving average?
          SYRE 20-day moving average is 18.44, which suggests SYRE is a Sell.
            What is SYRE’s 50-day moving average?
            SYRE’s 50-day moving average is 20.50, which suggests SYRE is a Sell.
              What is SYRE’s 200-day moving average?
              SYRE’s 200-day moving average is 26.24, which suggests SYRE is a Sell.
                What is SYRE’s Williams % R (14)?
                SYRE’s Williams % R (14) is -57.14, which suggests SYRE is a Buy.
                  What is SYRE’s CCI (14)?
                  SYRE’s CCI (14) is -88.90, which suggests SYRE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis